Tag Archives: BHTG

Maxim Group Maintains a Buy Rating on BioHiTech Global (BHTG)

Maxim Group analyst Tate Sullivan maintained a Buy rating on BioHiTech Global (BHTG – Research Report) today and set a price target of $4.00. The company’s shares closed last Wednesday at $2.05. According to TipRanks.com, Sullivan has 0 stars on

Maxim Group Thinks BioHiTech Global’s Stock is Going to Recover

Maxim Group analyst Tate Sullivan maintained a Buy rating on BioHiTech Global (BHTG – Research Report) today and set a price target of $2.50. The company’s shares closed last Wednesday at $1.12, close to its 52-week low of $1.01. According

Maxim Group Keeps Their Buy Rating on BioHiTech Global (BHTG)

Maxim Group analyst Tate Sullivan maintained a Buy rating on BioHiTech Global (BHTG – Research Report) on January 30 and set a price target of $3.50. The company’s shares closed last Monday at $2.00. According to TipRanks.com, Sullivan is currently

Maxim Group Keeps a Buy Rating on BioHiTech Global Inc (BHTG)

Maxim Group analyst Tate Sullivan maintained a Buy rating on BioHiTech Global Inc (BHTG – Research Report) yesterday and set a price target of $2.75. The company’s shares closed last Monday at $1.60, close to its 52-week low of $1.56.

Maxim Group Sticks to Its Buy Rating for BioHiTech Global Inc (BHTG)

Maxim Group analyst James Jang reiterated a Buy rating on BioHiTech Global Inc (BHTG – Research Report) today and set a price target of $7. The company’s shares opened today at $2.96. Jang commented: “BioHiTech Global (BHTG) reported 4Q18 results

Maxim Group Thinks BioHiTech Global Inc’s Stock is Going to Recover

In a report released yesterday, James Jang from Maxim Group reiterated a Buy rating on BioHiTech Global Inc (NASDAQ: BHTG), with a price target of $7. The company’s shares closed yesterday at $3.59, close to its 52-week low of $2.50.